INTRODUCTION: Skeletal muscle ischemia-reperfusion injury (I-R) is a complex injury process that includes damage to the sarcolemmal membrane, contributing to necrosis and apoptosis. MG53, a muscle-specific TRIM family protein, has been shown to be essential for regulating membrane repair and has been shown to be protective against cardiac I-R and various forms of skeletal muscle injury. The purpose of this study was to determine if recombinant human MG53 (rhMG53) administration offered protection against I-R. METHODS: rhMG53 was administered to rats immediately before tourniquet-induced ischemia and again immediately before reperfusion. Two days later muscle damage was assessed histologically. RESULTS: rhMG53 offered no protective effect, as evidenced primarily by similar Evans blue dye inclusion in the muscles of rats administered rhMG53 or saline. CONCLUSIONS: Administration of rhMG53 does not offer protection against I-R in rat skeletal muscle. Additional studies are required to determine if the lack of a response is species-specific. Published 2014 by Wiley Periodicals, Inc. This article is a US Government work and, as such, is in the public domain in the United States of America.
INTRODUCTION: Skeletal muscle ischemia-reperfusion injury (I-R) is a complex injury process that includes damage to the sarcolemmal membrane, contributing to necrosis and apoptosis. MG53, a muscle-specific TRIM family protein, has been shown to be essential for regulating membrane repair and has been shown to be protective against cardiac I-R and various forms of skeletal muscle injury. The purpose of this study was to determine if recombinant humanMG53 (rhMG53) administration offered protection against I-R. METHODS: rhMG53 was administered to rats immediately before tourniquet-induced ischemia and again immediately before reperfusion. Two days later muscle damage was assessed histologically. RESULTS: rhMG53 offered no protective effect, as evidenced primarily by similar Evans blue dye inclusion in the muscles of rats administered rhMG53 or saline. CONCLUSIONS: Administration of rhMG53 does not offer protection against I-R in rat skeletal muscle. Additional studies are required to determine if the lack of a response is species-specific. Published 2014 by Wiley Periodicals, Inc. This article is a US Government work and, as such, is in the public domain in the United States of America.
Authors: Joseph M White; Adam Stannard; Gabriel E Burkhardt; Brian J Eastridge; Lorne H Blackbourne; Todd E Rasmussen Journal: Ann Surg Date: 2011-06 Impact factor: 12.969
Authors: Michael C McCormack; Edwin Kwon; Kyle R Eberlin; Mark Randolph; Dan S Friend; Andrew C Thomas; Michael T Watkins; William G Austen Journal: Surgery Date: 2007-12-03 Impact factor: 3.982
Authors: Angela Lek; Frances J Evesson; Frances A Lemckert; Gregory M I Redpath; Ann-Katrin Lueders; Lynne Turnbull; Cynthia B Whitchurch; Kathryn N North; Sandra T Cooper Journal: J Neurosci Date: 2013-03-20 Impact factor: 6.167
Authors: Brian J Paleo; Kathryn M Madalena; Rohan Mital; Kevin E McElhanon; Thomas A Kwiatkowski; Aubrey L Rose; Jessica K Lerch; Noah Weisleder Journal: PLoS One Date: 2020-04-09 Impact factor: 3.240